# Enhancing Exposure Therapy for Post Traumatic Stress Disorder (PTSD): Virtual Reality and Imaginal Exposure With a Cognitive Enhancer

> **NCT01352637** · PHASE3 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 192 (actual)

## Conditions studied

- Post Traumatic Stress Disorder

## Interventions

- **DRUG:** DCS (D-Cycloserine ) + Prolonged Imaginal Exposure
- **DRUG:** DCS (D-Cycloserine ) + Virtual Reality Exposure
- **DRUG:** Placebo + Prolonged Imaginal Exposure
- **DRUG:** Placebo (sugar pill) + Virtual Reality Exposure

## Key facts

- **NCT ID:** NCT01352637
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 192 (ACTUAL)
- **Last updated:** 2019-07-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01352637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01352637, "Enhancing Exposure Therapy for Post Traumatic Stress Disorder (PTSD): Virtual Reality and Imaginal Exposure With a Cognitive Enhancer". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01352637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*